Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients

被引:43
|
作者
Yoshimura, Satoshi [1 ]
Isobe, Noriko [1 ]
Yonekawa, Tomomi [1 ]
Matsushita, Takuya [2 ]
Masaki, Katsuhisa [1 ]
Sato, Shinya [1 ]
Kawano, Yuji [3 ]
Yamamoto, Ken [4 ]
Kira, Jun-ichi [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Clin Neuroimmunol, Fukuoka 812, Japan
[3] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Matsuyama, Ehime 790, Japan
[4] Kyushu Univ, Med Inst Bioregulat, Res Ctr Genet Informat, Div Genome Anal, Fukuoka 812, Japan
来源
PLOS ONE | 2012年 / 7卷 / 11期
关键词
EPSTEIN-BARR-VIRUS; ANTI-AQUAPORIN-4; ANTIBODY; ENVIRONMENTAL-FACTORS; NEUROMYELITIS-OPTICA; DIAGNOSTIC-CRITERIA; ALLELES CORRELATE; DISEASE-ACTIVITY; HLA-A; RISK; HETEROGENEITY;
D O I
10.1371/journal.pone.0048592
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Nationwide surveys conducted in Japan over the past thirty years have revealed a four-fold increase in the estimated number of multiple sclerosis (MS) patients, a decrease in the age at onset, and successive increases in patients with conventional MS, which shows an involvement of multiple sites in the central nervous system, including the cerebrum and cerebellum. We aimed to clarify whether genetic and infectious backgrounds correlate to distinct disease phenotypes of MS in Japanese patients. Methodology/Principal Findings: We analyzed HLA-DRB1 and -DPB1 alleles, and IgG antibodies specific for Helicobacter pylori, Chlamydia pneumoniae, varicella zoster virus, and Epstein-Barr virus nuclear antigen (EBNA) in 145 MS patients and 367 healthy controls (HCs). Frequencies of DRB1*0405 and DPB1*0301 were significantly higher, and DRB1*0901 and DPB1*0401 significantly lower, in MS patients as compared with HCs. MS patients with DRB1*0405 had a significantly earlier age of onset and lower Progression Index than patients without this allele. The proportion and absolute number of patients with DRB1*0405 successively increased with advancing year of birth. In MS patients without DRB1*0405, the frequency of the DRB1*1501 allele was significantly higher, while the DRB1*0901 allele was significantly lower, compared with HCs. Furthermore, DRB1*0405-negative MS patients were significantly more likely to be positive for EBNA antibodies compared with HCs. Conclusions: Our study suggests that MS patients harboring DRB1*0405, a genetic risk factor for MS in the Japanese population, have a younger age at onset and a relatively benign disease course, while DRB1*0405-negative MS patients have features similar to Western-type MS in terms of association with Epstein-Barr virus infection and DRB1*1501. The recent increase of MS in young Japanese people may be caused, in part, by an increase in DRB1*0405-positive MS patients. Citation: Yoshimura S, Isobe N, Yonekawa T, Matsushita T, Masaki K, et al. (2012) Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients. PLoS ONE 7(11): e48592. doi:10.1371/journal.pone.0048592
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status
    Isobe, N.
    Matsushita, T.
    Yamasaki, R.
    Ramagopalan, S. V.
    Kawano, Y.
    Nishimura, Y.
    Ebers, G. C.
    Kira, J.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (02) : 147 - 155
  • [32] EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution
    Mescheriakova, Julia Y.
    van Nierop, Gijsbert P.
    van der Eijk, Annemiek A.
    Kreft, Karim L.
    Hintzen, Rogier Q.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (06):
  • [33] Sudden hearing loss as the initial symptom in Japanese patients with multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
    Tanaka, Masami
    Tanaka, Keiko
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 298 : 16 - 18
  • [34] BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases
    Braun, Tobias
    Juenemann, Martin
    Dornes, Kathrin
    El-Shazly, Jasmin
    Schramm, Patrick
    Bick-Ackerschott, Sandra
    Kaps, Manfred
    Gerriets, Tibo
    Blaes, Franz
    Tschernatsch, Marlene
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2021, 131 (12) : 1231 - 1236
  • [35] Epidemiology of Multiple Sclerosis
    Howard, Jonathan
    Trevick, Stephen
    Younger, David S.
    NEUROLOGIC CLINICS, 2016, 34 (04) : 919 - +
  • [36] Obesity interacts with infectious mononucleosis in risk of multiple sclerosis
    Hedstrom, A. K.
    Bomfim, I. Lima
    Hillert, J.
    Olsson, T.
    Alfredsson, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (03) : 578 - U70
  • [37] The Refinement of Genetic Predictors of Multiple Sclerosis
    Disanto, Giulio
    Dobson, Ruth
    Pakpoor, Julia
    Elangovan, Ramyiadarsini I.
    Adiutori, Rocco
    Kuhle, Jens
    Giovannoni, Gavin
    PLOS ONE, 2014, 9 (05):
  • [38] Genetic and environmental factors in multiple sclerosis
    Fernández, O
    REVISTA DE NEUROLOGIA, 2000, 30 (10) : 964 - 967
  • [39] A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis
    Saida, T.
    Kikuchi, S.
    Itoyama, Y.
    Hao, Q.
    Kurosawa, T.
    Nagato, K.
    Tang, D.
    Zhang-Auberson, L.
    Kira, J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (09) : 1269 - 1277
  • [40] Genetic burden in multiple sclerosis families
    Isobe, N.
    Damotte, V.
    Lo Re, V.
    Ban, M.
    Pappas, D.
    Guillot-Noel, L.
    Rebeix, I.
    Compston, A.
    Mack, T.
    Cozen, W.
    Fontaine, B.
    Hauser, S. L.
    Oksenberg, J. R.
    Sawcer, S.
    Gourraud, P-A
    GENES AND IMMUNITY, 2013, 14 (07) : 434 - 440